Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Title
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume -, Issue -, Pages -
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2018-09-25
DOI
10.1056/nejmoa1809697

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started